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ABSTRACT 
Background: Upto date, the scientific documentation regarding in-vitro antiurolithiatic activity of has been reported, although it has not 
reported for in-vitro antiurolithiatic activity up till now.  
Objective: To explore anti-urolithiatic activities of Pavonia lasiopetala leaves extract by utilizing different in-vitro models.  
Material and Methods: Aqueous extract of Pavonia lasiopetala fresh leaves was prepared and arranged in the different concentrations. 
Homogenous precipitation method was used to prepare artificial stones such as calcium oxalate and calcium phosphate and semi-permeable 
membrane of eggs was used as dissolution bags. Dissolution models were incubated in 72 hrs and after that, the entire content in dissolution 
bags was estimated spectrophotometrically. The inhibitory activity of Pavonia lasiopetala leaves extract on the nucleation of calcium oxalate 
crystals and the rate of aggregation in calcium oxalate crystals was determined by spectrophotometric assay. Results: In dissolution models, the 
extract of Pavonia lasiopetala has greater capability to dissolve calcium oxalate while Cystone standard has shown better demineralization for 
calcium phosphate rather than extract of Pavonia lasiopetala. Cystone exhibited strongly inhibitory action in the nucleation assay rather than 
aggregation assay. The extract of Pavonia lasiopetala exhibited inhibitory action in both of nucleation and aggregation assays to significant level.   
Discussion: Correlation between in-vitro and in-vivo studies may be helpful to understand the molecular mechanism of litholysis process and to 
reveal phytochemicals of the extract responsible for dissolving or disintegrating renal calculi.  
Conclusion: Pavonia lasiopetala extract exhibited significant in-vitro anti-urolithiatic activity.  
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INTRODUCTION  
Nowadays stone formation is the oldest and serious painful 
urologic disease with significant prevalence in the 
population due to change in lifestyle and dietary factors 1,2,3. 
Stone formation or lithiasis is characterized by calculi 
formation. It has two main types such as nephrolithiasis and 
urolithiasis 4,5,6. Calculi formation in urinary bladder, ureter 
or any part of urinary tract rather than kidney is known as 
urolithiasis while nephrolithiasis is characterized calculi 
formation in kidney 7,8,9. Generally, calcification for the 
formation of bone and teeth takes place in controlled 
biological situations 10,11. Uncontrolled pathological 
crystallization occurs when solvent becomes supersaturated 
leading to the formation of precipitates in the body called as 
kidney stones 12,13. 
Several medicinal plant extracts have been reported for in 
vitro anti-crystallization activities till date such as Herniaria 
hirsuta, Tribulus terrestris, Bergenia ciliate, Piper nigrum, 
Dolichos biflorus , Bergenia ligulata , Plantago major . 
Pavonia Lasiopetala. um is one of many medicinal plants as 
anti-urolitholytic known as traditionally folk medicine for 
Pavonia Lasiopetala  is a scientific term used in the Ayurveda 
system of medicine describing the potency of medicinal plant 
for breaking up and disintegrating renal and urinary calculi 
i.e., kidney stones and diuretic capacity 14,15. 
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MATERIAL AND METHODS 
Calcium chloride dihydrate, sodium oxalate, p-phenylene 
diamine were purchased from Sigma-Aldrich Ltd. Potassium 
permanganate, sodium meta-bisulfite, and trisbuffer were 
purchased from Sigma-Aldrich. Extraction Fresh leaves of 
Pavonia Lasiopetala were chopped into small pieces by hand 
and put into a conical flask. 100ml of distilled water was 
added to the conical flask and boiled for a while in order to 
maximize the extraction 16,17. After cooling it was filtered 
through Whatmann filter paper and as aqueous extract stock 
solution transferred to a suitable container. 
Preparation of the semi-permeable membrane from eggs 
Apex of eggs was punctured by a glass rod in order to 
squeeze out the entire content. Empty eggs were washed 
thoroughly with distilled water and placed in a beaker 
consisting 4ml concentrated HCl in 200ml distilled water. It 
was kept for overnight which led to the complete 
decalcification of semi permeable membrane 18. On the next 
day, semi permeable membranes were removed carefully 
from egg shells; washed thoroughly with distilled water and 
placed it in ammonia solution for neutralization of acid 
traces, and then rinsed it with distilled water. It was stored 
in refrigerator at a pH of 7-7.4 in the moistened condition. 
10mg of the calcium oxalate was suspended in 10ml of 
distilled water as negative control 19. 5ml of hot aqueous 
extract of fresh leaves of Pavonia Lasiopetala was taken. 
500mg tablet of Cystone was placed in absolute ethanol for 
removing colour coating and 400mg was obtained. Cystone 
tablet was crushed into powder form and dispersed into 
100ml of distilled water and filtered. Filtrate of Cystone was 
used as positive control for in vitro anti-urolithiatic activity. 
Group I: 1ml of calcium oxalate (1mg/ml) + 1ml of distilled 
water, Group II: 1ml of calcium oxalate (1mg/ml) + 1ml of 
Cystone solution (400mg/ml), Group III: 1ml of calcium 
oxalate (1mg/ml) + 1ml of hot aqueous extract of Pavonia 
Lasiopetala  (20mg/ml) 20. 
 
 
RESULTS & DISCUSSION 
Table 1: Dissolution of calcium oxalate 
Group Mean ± SEM Weight of calcium reduced Dissolution Percentage 
Group I 0.231 ± 0.0025   
Group II 0.083 ± 0.0037 0.087 77.32 
Group III 0.129 ± 0.014 0.071 51.75 
 
Table 2: Dissolution of calcium phosphate 
Group Mean ± SEM Weight of calcium reduced Dissolution Percentage 
Group I 0.214 ± 0.0025   
Group II 0.094 ± 0.0037 0.027 33.19 
Group III 0.123 ± 0.014 0.080 81.98 
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 As in vitro crystallization study was performed, since 
nucleation is an important first step for the initiation of 
crystals, which then grow and form aggregates. Extract of 
Pavonia Lasiopetala inhibited the crystallization by 
inhibiting nucleation of calcium oxalate through 
disintegrating into smaller particles with increasing 
concentrations of the fraction. From the results of the 
nucleation assay confirmed that the extract contained 
nucleation-preventing agents. No pharmacologic 
intervention has definitively been shown to be effective for 
lithiasis. The present investigation will be supportive as 
additional information to the scientific evidences regarding 
in-vitro studies 21.  
CONCLUSION 
Since mechanism of anti-urolitholytic activity in the extract 
is exact unknown till date, correlation between invitro and 
in-vivo studies should be further investigated to reveal the 
phytochemicals of the extract are responsible for dissolving 
or disintegrating renal calculi and to know better 
understanding in the molecular mechanism of litholysis. 
Pavonia Lasiopetala extract exhibited significant in-vitro 
anti-urolithiatic activity. 
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